COVID-19:

Ilias I Siempos1,2, Andre C Kalil3, Drifa Belhadi4,5

  • 1First Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

EClinicalMedicine
|February 16, 2024
PubMed
概括

免疫调节剂没有改变COVID-19免疫受损患者的结果. 这项研究发现,在接受这些治疗的脆弱群体中,死亡或二次感染的风险没有增加.

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163